Anbio Biotechnology Class A (NNNN) Balance Sheet
NNNN balance sheet, 2025
December 31, 2025 · U.S. dollars$30.2M assets = $87,836 liabilities + $30.2M equity
Both columns are drawn to the same scale: what NNNN owns equals what it owes plus shareholders’ equity. Hover a block for its value.
NNNN financial health
Descriptive bands, not a rating. Fiscal 2025.
NNNN balance sheet trends, 2021–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $4.9M2021 | $30.2M2025 | +57.5%/yr | |
| Total liabilities | $2.4M2021 | $87,8362025 | −56.2%/yr | |
| Shareholders’ equity | $2.5M2021 | $30.2M2025 | +85.7%/yr | |
| Cash & short-term investments | $4.2M2021 | $11.9M2025 | +29.9%/yr | |
| Working capital | $2.5M2021 | $30.2M2025 | +$27.6M | |
| Book value per share | $0.032021 | $0.692025 | +128.1%/yr | |
| Shares outstanding | 100.0M2021 | 43.9M2025 | −18.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
NNNN assets
NNNN liabilities and equity
NNNN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
NNNN balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $11.9M | $11.8M | $9.7M | $8.7M | $4.2M |
| Cash & equivalents | $7.8M | $11.8M | $9.7M | $7.1M | $4.2M |
| Short-term investments | $4.1M | $0 | $0 | $1.6M | $0 |
| Receivables | $3.7M | $1.1M | $1.9M | $3,581 | $717,500 |
| Inventory | $0 | $0 | $0 | $353,872 | $0 |
| Other current assets | $14.7M | $5.7M | $4.2M | $4.9M | $16,854 |
| Total current assets | $30.2M | $18.5M | $15.7M | $13.9M | $4.9M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $12,059 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $387,440 | $62,137 | $2,989 | $0 |
| Total assets | $30.2M | $18.9M | $15.8M | $14.0M | $4.9M |
| Liabilities | |||||
| Accounts payable | $0 | $1.6M | $827,151 | $1.4M | $1.9M |
| Deferred revenue | — | — | — | — | $490,000 |
| Total current liabilities | $87,836 | $1.7M | $993,060 | $1.4M | $2.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $87,836 | $1.7M | $993,060 | $1.4M | $2.4M |
| Shareholders' equity | |||||
| Common stock & paid-in capital | $14,389 | $14,229 | $14,229 | — | — |
| Retained earnings (deficit) | $23.6M | $17.2M | $14.8M | $12.5M | $2.5M |
| Total shareholders' equity | $30.2M | $17.2M | $14.8M | $12.5M | $2.5M |
| Key figures | |||||
| Working capital | $30.2M | $16.8M | $14.8M | $12.5M | $2.5M |
| Tangible book value | $30.2M | $17.2M | $14.8M | $12.5M | $2.5M |
| Book value per share | $0.69 | $0.41 | $0.08 | $0.09 | $0.03 |
| Shares outstanding | 43.9M | 42.3M | 187.8M | 143.9M | 100.0M |
| Current ratio | 344.31 | 10.71 | 15.86 | 9.88 | 2.07 |
| Quick ratio | 177.13 | 7.41 | 11.65 | 6.15 | 2.06 |
| Equity / assets | 99.7% | 90.9% | 93.7% | 89.9% | 51.6% |
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Jun '24 | Dec '23 | Jun '23 | Dec '22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $11.9M | $11.9M | $11.9M | $15.8M | $13.4M | $11.8M | $10.3M | $9.7M | $10.6M | $8.7M |
| Cash & equivalents | $7.8M | $7.8M | $7.8M | $6.3M | $5.3M | $11.8M | $10.3M | $9.7M | $10.6M | $7.1M |
| Short-term investments | $4.1M | $4.1M | $4.1M | $9.5M | $8.1M | $0 | — | $0 | $0 | $1.6M |
| Receivables | $3.7M | $3.7M | $3.7M | $4.4M | $3.7M | $1.1M | $4.6M | $1.9M | $3,581 | $3,581 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $353,872 |
| Other current assets | $14.7M | $14.7M | $14.7M | $12.4M | $10.5M | $5.7M | $3.8M | $4.2M | $4.6M | $4.9M |
| Total current assets | $30.2M | $30.2M | $30.2M | $32.5M | $27.7M | $18.5M | $18.8M | $15.7M | $15.1M | $13.9M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3,273 | $12,059 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $387,440 | $176,993 | $62,137 | $276,798 | $2,989 |
| Total assets | $30.2M | $30.2M | $30.2M | $32.5M | $27.7M | $18.9M | $18.9M | $15.8M | $15.4M | $14.0M |
| Liabilities | ||||||||||
| Accounts payable | — | $0 | — | $70,841 | $60,350 | $1.6M | $478,960 | $827,151 | $1.3M | $1.4M |
| Total current liabilities | $87,836 | $87,836 | $87,836 | $153,923 | $131,127 | $1.7M | $527,753 | $993,060 | $1.3M | $1.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $87,836 | $87,836 | $87,836 | $153,923 | $131,127 | $1.7M | $527,753 | $993,060 | $1.3M | $1.4M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $14,389 | — | $14,389 | $16,890 | $14,389 | $14,229 | $14,229 | $14,229 | $14,229 | — |
| Retained earnings (deficit) | $23.6M | $23.6M | $23.6M | $24.6M | $21.0M | $17.2M | $18.4M | $14.8M | $14.1M | $12.5M |
| Total shareholders' equity | $30.2M | $30.2M | $30.2M | $32.3M | $27.5M | $17.2M | $18.4M | $14.8M | $14.1M | $12.5M |
| Key figures | ||||||||||
| Working capital | $30.2M | $30.2M | $30.2M | $32.3M | $27.5M | $16.8M | $18.2M | $14.8M | $13.8M | $12.5M |
| Tangible book value | $30.2M | $30.2M | $30.2M | $32.3M | $27.5M | $17.2M | $18.4M | $14.8M | $14.1M | $12.5M |
| Book value per share | $0.69 | $0.69 | $0.69 | $0.74 | $0.63 | $0.41 | $0.44 | $0.35 | $0.33 | — |
| Shares outstanding | 43.9M | 43.9M | 43.9M | 43.9M | 43.4M | 42.3M | 42.3M | 42.3M | 42.3M | — |
| Current ratio | 344.31 | 344.31 | 344.31 | 211.10 | 211.10 | 10.71 | 35.56 | 15.86 | 11.29 | 9.88 |
| Quick ratio | 177.13 | 177.12 | 177.12 | 130.75 | 130.75 | 7.41 | 28.28 | 11.65 | 7.87 | 6.15 |
| Equity / assets | 99.7% | 99.7% | 99.7% | 99.5% | 99.5% | 90.9% | 97.2% | 93.7% | 91.3% | 89.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 7, 2026); data from EODHD.
NNNN financial position
At the end of fiscal 2025 (December 31, 2025), Anbio Biotechnology had total assets of $30.2 million (up 59.8% from a year earlier), total liabilities of $0.1 million and shareholders' equity of $30.2 million. Its current ratio was 344.31. In the latest quarter (ended March 31, 2026) total assets were $30.2 million and equity $30.2 million.
Related: NNNN income statement, NNNN cash flow statement, NNNN key metrics. See the NNNN stock overview for the latest quote and news.
NNNN balance sheet FAQ
What are Anbio Biotechnology's total assets?
Anbio Biotechnology reported total assets of $30.2 million at the end of fiscal 2025 (December 31, 2025), compared with $18.9 million a year earlier.
How much cash does Anbio Biotechnology have?
Anbio Biotechnology held $11.9 million in cash and short-term investments at the end of fiscal 2025.
What is Anbio Biotechnology's book value?
Anbio Biotechnology's shareholders' equity (book value) was $30.2 million at the end of fiscal 2025, or $0.69 per share.
What is Anbio Biotechnology's current ratio?
Anbio Biotechnology had current assets of $30.2 million and current liabilities of $0.1 million, a current ratio of 344.31 (it can cover its short-term obligations).